{
  "ticker": "GLPG",
  "company_name": "Galapagos NV",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01887106",
      "title": "First-in-Human Single and Multiple Dose of GLPG1205",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2013-06",
      "completion_date": "2013-10",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT03207815",
      "title": "Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Noninfectious Uveitis",
      "start_date": "2017-07-26",
      "completion_date": "2021-04-22",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    },
    {
      "nct_id": "NCT04856358",
      "title": "A Study to Evaluate How Well Single and Multiple Doses of GLPG3121-modified Release Formulation Are Tolerated in Healthy, Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2021-04-27",
      "completion_date": "2021-11-08",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT03417778",
      "title": "Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Rheumatoid Arthritis",
      "start_date": "2018-04-03",
      "completion_date": "2018-08-09",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    },
    {
      "nct_id": "NCT02662452",
      "title": "First-in-Human Single and Multiple Dose of GLPG2222",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2016-01",
      "completion_date": "2016-05",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT04653467",
      "title": "A Study to Evaluate How Well Single and Multiple Doses of GLPG4399 Are Tolerated in Healthy, Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2020-11-06",
      "completion_date": "2022-01-10",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT03474042",
      "title": "GLPG2737 on Top of Orkambi in Subjects With Cystic Fibrosis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Cystic Fibrosis",
      "start_date": "2017-11-29",
      "completion_date": "2018-04-10",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT01665924",
      "title": "Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2012-07",
      "completion_date": "2012-10",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT03711162",
      "title": "A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Idiopathic Pulmonary Fibrosis",
      "start_date": "2018-11-28",
      "completion_date": "2021-03-30",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT04577781",
      "title": "A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Rheumatoid Arthritis",
      "start_date": "2020-10-12",
      "completion_date": "2021-04-07",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1": 26,
      "PHASE2": 15,
      "PHASE3": 7,
      "": 1,
      "NA": 1
    },
    "by_status": {
      "COMPLETED": 41,
      "TERMINATED": 6,
      "UNKNOWN": 1,
      "RECRUITING": 1,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 2,
    "completed_trials": 41,
    "conditions": [
      "Ankylosing Spondylitis",
      "Atopic Dermatitis",
      "Bioavailability",
      "Crohn's Disease",
      "Cystic Fibrosis",
      "Dermatomyositis",
      "Healthy",
      "Healthy, Dermatitis, Atopic",
      "Hematological Malignancies",
      "Idiopathic Pulmonary Fibrosis",
      "Noninfectious Uveitis",
      "Primary Sj\u00f6gren Syndrome",
      "Psoriatic Arthritis",
      "Rheumatoid Arthritis",
      "Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Non-Radiographical Axial Spondyloarthritis",
      "Ulcerative Colitis"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:44:10.177728",
    "search_query": "Galapagos NV",
    "url": "https://clinicaltrials.gov/search?term=Galapagos+NV"
  }
}